Research Article
National Eye Institute Visual Function Scale in Type 2 Diabetes Patients
Table 6
Questionnaire scores according to demographic data.
(a) |
| | | General health | General vision | Ocular pain | Near activities | Distance activities | Social functioning | Mental health |
| Age | | | | | | | | | ≤50 | 32 | 50.85 ± 17.31 | 57.10 ± 20.88 | 73.28 ± 22.93 | 74.91 ± 28.90 | 77.07 ± 18.28 | 90.23 ± 16.28 | 65.62 ± 28.47 | 51–60 | 78 | 44.58 ± 16.76 | 52.08 ± 19.10 | 78.68 ± 19.85 | 74.00 ± 23.26 | 83.26 ± 17.40 | 92.14 ± 13.66 | 74.72 ± 25.43 | 61–70 | 60 | 47.70 ± 16.09 | 54.66 ± 14.89 | 78.95 ± 20.77 | 76.98 ± 22.73 | 74.02 ± 27.46 | 83.77 ± 25.83 | 63.75 ± 31.80 | ≥71 | 31 | 41.20 ± 14.41 | 54.11 ± 17.49 | 77.82 ± 19.55 | 78.38 ± 18.09 | 83.67 ± 18.54 | 87.63 ± 17.26 | 77.82 ± 22.60 | | | 0.08 | 0.59 | 0.60 | 0.79 | 0.04 | 0.07 | 0.03 | Gender | | | | | | | | | Female | 103 | 43.98 ± 16.20 | 54.22 ± 17.77 | 73.30 ± 20.63 | 75.76 ± 23.30 | 81.49 ± 20.49 | 90.49 ± 16.54 | 72.04 ± 28.20 | Male | 98 | 48.11 ± 16.55 | 53.69 ± 18.24 | 82.47 ± 19.45 | 75.66 ± 23.38 | 77.57 ± 22.36 | 86.70 ± 21.47 | 68.83 ± 27.77 | | | 0.07 | 0.83 | 0.001 | 0.97 | 0.19 | 0.16 | 0.41 | HTN | | | | | | | | | Present | 126 | 44.10 ± 16.11 | 52.93 ± 17.72 | 79.86 ± 20.24 | 77.71 ± 22.09 | 81.26 ± 19.62 | 90.18 ± 17.27 | 72.01 ± 26.83 | Not present | 75 | 49.16 ± 16.68 | 55.70 ± 18.34 | 74.26 ± 20.68 | 72.36 ± 24.95 | 76.77 ± 24.11 | 86.05 ± 21.84 | 67.89 ± 29.80 | | | 0.03 | 0.29 | 0.06 | 0.11 | 0.15 | 0.16 | 0.31 |
|
|
(b) |
| | | Role difficulties | Visual dependency | Driving | Color vision | Peripheral vision | Total score |
| Age | | | | | | | | ≤50 | 32 | 62.10 ± 29.69 | 85.74 ± 23.07 | 41.66 ± 35.35 | 91.40 ± 18.63 | 78.12 ± 24.38 | 74.29 ± 17.41 | 51–60 | 78 | 76.12 ± 25.07 | 89.67 ± 22.81 | 69.26 ± 33.43 | 94.55 ± 15.93 | 81.08 ± 23.89 | 79.91 ± 14.84 | 61–70 | 60 | 63.22 ± 34.27 | 75.47 ± 32.96 | 54.16 ± 29.24 | 89.83 ± 19.76 | 71.66 ± 28.17 | 71.15 ± 22.96 | ≥71 | 31 | 74.03 ± 25.01 | 87.50 ± 22.47 | 76.18 ± 20.65 | 90.51 ± 16.92 | 82.25 ± 23.44 | 79.82 ± 17.16 | | | 0.02 | 0.01 | 0.16 | 0.43 | 0.12 | 0.02 | Gender | | | | | | | | Female | 103 | 72.33 ± 27.84 | 85.20 ± 27.70 | 64.26 ± 31.40 | 93.38 ± 16.47 | 78.64 ± 24.10 | 77.65 ± 18.03 | Male | 98 | 66.97 ± 30.70 | 83.71 ± 25.83 | 58.79 ± 31.37 | 90.62 ± 18.93 | 77.29 ± 26.88 | 75.06 ± 19.24 | | | 0.19 | 0.69 | 0.57 | 0.27 | 0.70 | 0.32 | HTN | | | | | | | | Present | 126 | 71.33 ± 27.76 | 85.45 ± 25.82 | 63.50 ± 30.89 | 92.33 ± 17.21 | 78.96 ± 24.98 | 77.33 ± 17.87 | Not present | 75 | 67.00 ± 31.77 | 82.82 ± 28.34 | 59.16 ± 32.51 | 91.55 ± 18.63 | 76.33 ± 26.28 | 74.79 ± 19.85 | | | 0.32 | 0.50 | 0.66 | 0.76 | 0.47 | 0.35 |
|
|
HTN: hypertension; one-way ANOVA; -test.
|